Starting from the importance to simultaneously investigate multiple biomarkers in different breast diseases (like atypia and cancer) to avoid pitfalls, shortcomings and false discovery of candidate biomarkers[17,20], the multiple combination of well known biomarkers (TF, uPA and PAI-1) significantly contribute to the improvement of earlier diagnosis and prognosis of BC. The gene discussed is PLAU; the disease is cancer.